LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy
The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings
The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings
Crosslinking mass spectrometry (XL-MS) can leverage the PhoX Crosslinker and TIMS/PASEF methods with the large-scale use of accurate collision cross sections
The new reagent kits aim to make whole genome sequencing more accessible and affordable for labs of all sizes
This powerful new solution aims to provide more accurate COVID-19 antibody detection
Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing
Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing
Join us on Wednesday, August 26, to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours
BLENREP is the fifth major medicine approval for GSK in 2020
Ideal for cell and gene therapy and COVID-19 research, BioStore IIIv offers inventory control and reporting capabilities
The modular solution aims to deliver test results in a four-step process requiring minimal hands-on time, laboratory space and staffing resources
Exclusive interviews, new methods, free downloads, and much more to help you advance your work
Watch this on-demand webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine
87 percent of patients in ZUMA-2 pivotal trial responded to single infusion of Tecartus
New platform provides faster identification of defects that impact device performance
Leading clinical scientists and health professionals have come together to discuss the latest diagnostic and point-of-care solutions at this critical time
The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting
Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and Europe
Find out how LC-MS technology is being used to quantify the experimental drug remdesivir
The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test
The NeuroSphere Digital Care offers flexible virtual care options as the COVID-19 global pandemic impacts how healthcare is administered
Thermo Fisher Scientific’s ImmunoCAP Specific IgE alpha-Gal Allergen Component test helps clinicians pinpoint a potentially fatal allergy often resulting from tick bites
This on-demand webinar shows how cutting-edge liquid handling, automation, and detection technologies can increase speed and efficiency in your lab
AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage
Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)